Clostridium difficile (CDF) Stool Sample Preparation Kit 30-002-022Recalls & reported problems
Luminex Corporation · The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI). · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 0
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
No MAUDE adverse event reports in our data reference this device identifier directly.
1 FDA recall record name this device's identifier, 1 still open.
4 other recalls cover devices cleared under the same FDA submission (K123197); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Recalls naming this device
- Jun 17, 2022Open, Classified
There is a potential for false negative results using VERIGENE CDF Stool PREP KIT and VERIGENE EP Stool PREP KIT due to hydrophobic characteristics of the swab.
Z-1334-2022 · Root cause: Nonconforming Material/Component · Recall details · FDA record ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K123197. One submission often covers many models, so check the product and lot details in each record.
- Z-2024-2023 · Jun 5, 2023 · Open, ClassifiedVERIGENE Clostridium difficile Nucleic Acid Test, REF 30-002-022
- Z-2010-2021 · Oct 30, 2020 · Open, ClassifiedVerigene Clostridium difficile Nucleic Acid Test Kit (CDF) Model Number: 20-006-022
- Z-2168-2014 · Oct 16, 2013 · TerminatedNanosphere Verigene Each CDF test consists of a Verigene CDF Nucleic Acid Test Kit and a Verigene CDF Amplification Reagent Kit. The Verigene Clostridium difficile Nucleic Acid
- Z-2682-2014 · Oct 10, 2013 · TerminatedThe Verigene Clostridium difficile Nucleic Acid Test (CDF) is a qualitative, multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcd
Other C. Difficile toxin gene amplification assay devices
- Revogene C. difficile 410300Meridian Bioscience, Inc. · C. Difficile Toxin Gene Amplification Assay1 recall0 reports
- BD MAX™ Cdiff (US) 443418Becton, Dickinson And Company · C.Difficile toxin gene amplification assay2 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page